VedaLab
Private Company
Funding information not available
Overview
VedaLab is a well-established, privately held French diagnostics company with over 30 years of experience in developing and manufacturing rapid immunodiagnostic tests. Operating from a modern ISO 13485 certified facility in Alençon, Normandy, the company has a broad portfolio spanning infectious diseases (e.g., COVID-19, influenza, RSV, toxoplasmosis), drugs of abuse, and quantitative tests (e.g., Vitamin D, NT-proBNP). With a strong emphasis on R&D and manufacturing control, VedaLab leverages its patented technologies and proprietary equipment to serve a global market across 170+ countries, targeting both professional and direct-to-consumer segments.
Technology Platform
Immunochromatography (lateral flow) platform with proprietary manufacturing equipment and patented technologies for qualitative and quantitative rapid diagnostic tests.
Opportunities
Risk Factors
Competitive Landscape
VedaLab competes in a crowded global rapid test market against large players like Abbott, Roche, and Siemens, as well as numerous other specialized IVD companies. Its differentiation lies in its European-based vertical integration (full manufacturing control), a broad portfolio spanning professional and home use, and a focus on patented technologies and proprietary equipment.